Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy (Q34580311)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy (English)

1 reference

Europe PubMed Central

3 August 2017

object named as

Antoine Muchir

1

0 references

object named as

Paul Pavlidis

2

0 references

object named as

Gisèle Bonne

3

0 references

author name string

Yukiko K Hayashi

4

1 reference

Europe PubMed Central

3 August 2017

Howard J Worman

5

1 reference

Europe PubMed Central

3 August 2017

publication date

13 June 2007

1 reference

Europe PubMed Central

3 August 2017

Human Molecular Genetics

1 reference

Europe PubMed Central

3 August 2017

16

1 reference

Europe PubMed Central

3 August 2017

15

1 reference

Europe PubMed Central

3 August 2017

1884-1895

1 reference

Europe PubMed Central

3 August 2017

Emery-Dreifuss muscular dystrophy - a 40 year retrospective

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Multiple and surprising new functions for emerin, a nuclear membrane protein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Keratin-like proteins that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Disruption of nuclear lamin organization blocks the elongation phase of DNA replication

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The inner nuclear membrane

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Direct interaction between emerin and lamin A

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Interaction between emerin and nuclear lamins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The nuclear envelope and human disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Genetic causes of human heart failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Altered intracellular Ca2+ handling in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Evaluation of methods for oligonucleotide array data via quantitative real-time PCR

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Mitogen-activated protein kinases in the heart

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Pharmacological inhibitors of MAPK pathways.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

ErmineJ: tool for functional analysis of gene expression data sets

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The nuclear lamina is a meshwork of intermediate-type filaments

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Identifiers

10.1093/HMG/DDM137

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34580311&oldid=1593639675"